Clinical Trial Update: A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing SHR-1139 injection with placebo in adults with moderate-to-severe plaque psoriasis; the study is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• SHR-1139

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Moderate to Severe Plaque Psoriasis | Phase 2 | Status: ACTIVE_NOT_RECRUITING